These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6236289)

  • 1. Depressed T lymphocyte function in brain tumor patients: monocytes as suppressor cells.
    Wood GW; Morantz RA
    J Neurooncol; 1983; 1(2):87-94. PubMed ID: 6236289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro reversal of depressed T-lymphocyte function in the peripheral blood of brain tumor patients.
    Wood GW; Morantz RA
    J Natl Cancer Inst; 1982 Jan; 68(1):27-33. PubMed ID: 6172627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas.
    Braun DP; Penn RD; Flannery AM; Harris JE
    Neurosurgery; 1982 Feb; 10(2):203-9. PubMed ID: 6280097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.
    Elliott LH; Brooks WH; Roszman TL
    J Immunol; 1984 Mar; 132(3):1208-15. PubMed ID: 6319491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological monitoring of brain tumors--prognosis based on T-lymphocyte subpopulations and skin testing for delayed hypersensitivity].
    Yokoyama H; Nakadai M; Asou Y; Maeda T; Ogashiwa M; Takeuchi K
    No To Shinkei; 1985 Feb; 37(2):193-9. PubMed ID: 3873952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro analysis of the proliferative potential of T cells from patients with brain tumor: glioma-associated immunosuppression unrelated to intrinsic cellular defect.
    McVicar DW; Davis DF; Merchant RE
    J Neurosurg; 1992 Feb; 76(2):251-60. PubMed ID: 1730954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunobiology of primary intracranial tumors. VI. Suppressor cell function and lectin-binding lymphocyte subpopulations in patients with cerebral tumors.
    Roszman TL; Brooks WH; Elliott LH
    Cancer; 1982 Oct; 50(7):1273-9. PubMed ID: 6213292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of human T lymphocytes to phytohemagglutinin (PHA) after sequential depletion of monocytes, HLA-DR+, Leu11a+, and Leu7+ cells.
    Ulmer AJ; Scholz W; Ernst M; Flad HD
    Immunobiology; 1985 Dec; 170(5):419-33. PubMed ID: 2936677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of suppressor cells in depression of T lymphocyte proliferative response in untreated and treated Hodgkin's disease.
    Han T
    Cancer; 1980 Apr; 45(8):2102-8. PubMed ID: 6445226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong suppression by monocytes of T cell mitogenesis in chicken peripheral blood leukocytes.
    Schaefer AE; Scafuri AR; Fredericksen TL; Gilmour DG
    J Immunol; 1985 Sep; 135(3):1652-60. PubMed ID: 3160775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of monocyte function in patients with cervical cancer by using T-lymphocyte monocyte interaction in response to phytohemagglutinin (author's transl)].
    Umesaki N; Nakade J; Nakamori H; Sako H; Lee T; Sugawa T
    Acta Obstet Gynaecol Jpn; 1981 May; 33(5):664-70. PubMed ID: 6972146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses in patients with brain tumors. Factors such as anti-convulsants that may contribute to impaired cell-mediated immunity.
    Neuwelt EA; Kikuchi K; Hill S; Lipsky P; Frenkel EP
    Cancer; 1983 Jan; 51(2):248-55. PubMed ID: 6821814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics and immunologic changes in patients with malignant brain tumors].
    Khonina NA; Tsentner MI; Leplina OIu; Tikhonova MA; Stupak VV; Nikonov SD; Chërnykh ER; Ostanin AA
    Vopr Onkol; 2002; 48(2):196-201. PubMed ID: 12227068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of immunoregulatory lymphocytes obtained from patients with malignant gliomas.
    Elliott LH; Brooks WH; Roszman TL
    J Neurosurg; 1987 Aug; 67(2):231-6. PubMed ID: 2885402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients.
    Braun DP; Harris JE
    J Natl Cancer Inst; 1981 Oct; 67(4):809-14. PubMed ID: 6974273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic concepts in glioma immunology.
    Parney IF
    Adv Exp Med Biol; 2012; 746():42-52. PubMed ID: 22639158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of monocytes to the decreased lymphoproliferative response to phytohemagglutinin in patients with lung cancer.
    Fariñas MC; Rodriguez-Valverde V; Zarrabeitia MT; Parra-Blanco JA; Sanz-Ortiz J
    Cancer; 1991 Sep; 68(6):1279-84. PubMed ID: 1873782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumors.
    Brooks WH; Roszman TL; Rogers AS
    Cancer; 1976 Apr; 37(4):1869-73. PubMed ID: 769940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
    Kunicka JE; Platsoucas CD
    Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of natural killer cell function by glass-adherent cells in patients with primary intracranial malignancies.
    Braun DP; Penn RD; Harris JE
    Neurosurgery; 1984 Jul; 15(1):29-33. PubMed ID: 6089029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.